Stefan von Berg

Structural Insights and Biological Effects of Glycogen Synthase Kinase 3-specific Inhibitor AR-A014418

Ratan V. Bhat, Yafeng Xue, Stefan von Berg et al. · Journal of Biological Chemistry · 2003 · 550 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +16

A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation

Dominik Paquet, Ratan V. Bhat, Astrid Sydow et al. · Journal of Clinical Investigation · 2009 · 273 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Discovery of Novel Potent and Highly Selective Glycogen Synthase Kinase-3β (GSK3β) Inhibitors for Alzheimer’s Disease: Design, Synthesis, and Characterization of Pyrazines

Stefan von Berg, Margareta Bergh, Sven Hellberg et al. · Journal of Medicinal Chemistry · 2012 · 150 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease

Fredrik Jeppsson, Susanna Eketjäll, Juliette Janson et al. · Journal of Biological Chemistry · 2012 · 138 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

<scp>AZD</scp>1080, a novel <scp>GSK</scp>3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans

Biljana Georgievska, Johan Sandin, James Doherty et al. · Journal of Neurochemistry · 2013 · 118 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17